Triglyceride production (None)

Triglyceride production refers to the multi-step biochemical process by which cells synthesize triglycerides from glycerol and fatty acids. This occurs primarily in the endoplasmic reticulum of hepatocytes and adipocytes through sequential enzymatic reactions involving acyltransferases such as glycerol-3-phosphate acyltransferase (GPAT), acylglycerophosphate acyltransferase (AGPAT), phosphatidic acid phosphatase (PAP), and diacylglycerol O-acyltransferases 1/2 (DGAT1/2). The resulting triglycerides serve critical roles in energy storage and lipid transport via very-low-density lipoproteins (VLDL). Dysregulation of this process contributes significantly to metabolic diseases including obesity, hypertriglyceridemia, cardiovascular disease, and non-alcoholic fatty liver disease. While “triglyceride production” itself is not a single molecular target suitable for drug development or biomarker use, several component enzymes within its biosynthetic pathways are established therapeutic targets under active investigation[1][4][5].

Other names

Triglyceride synthesisTriacylglycerol biosynthesisTAG synthesis

Drugs targeting triglyceride biosynthesis typically act by inhibiting key enzymatic steps such as those catalyzed by DGATs or GPATs—thereby reducing triglyceride formation and lowering circulating lipid levels[1].